707 related articles for article (PubMed ID: 17327355)
1. Impaired fasting glucose and impaired glucose tolerance: implications for care.
Nathan DM; Davidson MB; DeFronzo RA; Heine RJ; Henry RR; Pratley R; Zinman B;
Diabetes Care; 2007 Mar; 30(3):753-9. PubMed ID: 17327355
[No Abstract] [Full Text] [Related]
2. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
Szurkowska M; Szafraniec K; Gilis-Januszewska A; Pach D; Krzentowska A; Szybiński Z; Huszno B
Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
[TBL] [Abstract][Full Text] [Related]
5. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
Guerrero-Romero F; Violante R; Rodríguez-Morán M
Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
[TBL] [Abstract][Full Text] [Related]
7. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
[TBL] [Abstract][Full Text] [Related]
8. Progression from newly acquired impaired fasting glucose to type 2 diabetes: response to Nichols et al.
Dinneen SF; Rizza RA
Diabetes Care; 2007 Jul; 30(7):e79; author reply e80. PubMed ID: 17596502
[No Abstract] [Full Text] [Related]
9. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
[TBL] [Abstract][Full Text] [Related]
10. Recruiting high-risk individuals to a diabetes prevention program: how hard can it be?
Ruge T; Nyström L; Lindahl B; Hallmans G; Norberg M; Weinehall L; Rolandsson O
Diabetes Care; 2007 Jul; 30(7):e61. PubMed ID: 17596484
[No Abstract] [Full Text] [Related]
11. Prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose.
Florkowski CM; Beaven DW
N Z Med J; 2007 Aug; 120(1259):U2674. PubMed ID: 17721578
[No Abstract] [Full Text] [Related]
12. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
Harati H; Hadaegh F; Tohidi M; Azizi F
Diabetes Res Clin Pract; 2009 Jul; 85(1):90-5. PubMed ID: 19414206
[TBL] [Abstract][Full Text] [Related]
13. The likelihood of diabetes based on the proposed definitions for impaired fasting glucose.
Gao W; Dong Y; Nan H; Tuomilehto J; Qiao Q
Diabetes Res Clin Pract; 2008 Jan; 79(1):151-5. PubMed ID: 17825938
[TBL] [Abstract][Full Text] [Related]
14. Glucose tolerance status and 20 year cancer incidence.
Dankner R; Chetrit A; Segal P
Isr Med Assoc J; 2007 Aug; 9(8):592-6. PubMed ID: 17877065
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significant of intervention of impaired glucose tolerance and some problems in the treatment].
Xu ZR
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1765-7. PubMed ID: 15631768
[No Abstract] [Full Text] [Related]
16. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
[TBL] [Abstract][Full Text] [Related]
17. [Development of health-risk appraisal in impaired glucose tolerance].
Sakane N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():614-9. PubMed ID: 15779449
[No Abstract] [Full Text] [Related]
18. Impaired fasting glucose versus impaired glucose tolerance.
Rajendran B
J Assoc Physicians India; 2002 Apr; 50():614; author reply 614-5. PubMed ID: 12164431
[No Abstract] [Full Text] [Related]
19. Implications for primary care of diabetes and impaired fasting glucose prevalence in adolescents.
Rosenbloom AL
Arch Pediatr Adolesc Med; 2006 May; 160(5):550-2. PubMed ID: 16651502
[No Abstract] [Full Text] [Related]
20. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
